期刊文献+

非酒精性脂肪肝的诊断与治疗 被引量:1

下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是西方常见的肝脏疾病,经人口学调查约20%~30%的西方人患有NAFLD。随着人们生活水平的提高、生活方式的改变及医疗技术的提高,我国的NAFLD也呈升高的趋势,由于NAFLD与肝细胞脂肪变性、非酒精性脂肪性肝炎(NASH)、肝脏纤维化、肝硬化密切相关,所以也日益引起临床医生的重视。笔者将近期较受临床关注的NAFLD的诊断与治疗方法综述如下。
出处 《天津医药》 CAS 北大核心 2007年第11期873-875,共3页 Tianjin Medical Journal
  • 相关文献

参考文献25

  • 1Neuschwander Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference [J]. Hepatology, 2003,37(5): 1202-1219. 被引量:1
  • 2Bedogni G, Bellentani S. Fatty liver:how frequent is it and why[J]? Ann Hepatol, 2004,3 ( 2 ) : 63-65. 被引量:1
  • 3吴敏,李运红,杨建,金志斌,张克南,徐肇敏.四个地区脂肪肝调查分析[J].中华消化杂志,2005,25(2):122-123. 被引量:19
  • 4Giorgio B,Lucia M,Flora M,et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study[J]. Hepatology, 2005,42( 1 ) :44-52. 被引量:1
  • 5Leon A,Ariel F,Keith D,et al. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction [J]. Hepatology, 2004,39(4 ) : 909-914. 被引量:1
  • 6Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 7Hickman IJ,Jonsson JR,Prins JB,et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life[J]. Gut, 2004,53 ( 3 ) : 413-419. 被引量:1
  • 8Elisabetta B, Elena G, Rita M, et al. A randomized controlled trial of mefformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease[J]. Am J Gastroenterol, 2005,100(5 ) : 1082-1090. 被引量:1
  • 9周建烈,张颖.《2005年美国膳食指南》简介[J].营养学报,2005,27(2):89-91. 被引量:9
  • 10John B, Prithi S, Norman R, et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss[J]. Hepatology ,2004,39(6) : 1647-1654. 被引量:1

二级参考文献37

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2王吉耀.脂肪肝临床流行病学[J].中华肝脏病杂志,2000,8(4):115-115. 被引量:85
  • 3葛可佑.中国营养科学全书[M].北京:人民卫生出版社,2004.1049-1056. 被引量:380
  • 4Pagano G, Pacini G, Musso G, et al. Nonalcoholic steanhepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association[ J]. Hepatology, 2002,35 ( 2 ): 367 - 72. 被引量:1
  • 5McCullongh AJ. Update on nonalcoholic fatty liver disease [ J ]. J Clin Gasteroenterol, 2002,34(3) :255 - 62. 被引量:1
  • 6Mehta K, Van Thiel DH, Shah N, et al. Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants. Nutr Rev ,2002,60:289 293. 被引量:1
  • 7顾景范.美国膳食指南2000年新版本及其启示[J].营养与食品卫生,2001,9:12-13. 被引量:1
  • 8.[EB/OL].http://www. healthierus. gov/dietaryguidelines,. 被引量:1
  • 9Maeda N, Takahashi M, Funahashi T, et al. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose derived protein. Diabetes, 2001, 50:2094-2099. 被引量:1
  • 10Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose- derived anti inflammatory protein, adiponectin. J Clin Endocrinol Metab, 2001,86: 3815-3819. 被引量:1

共引文献1566

同被引文献34

引证文献1

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部